Catalyst Wire Dossier Catalyst Wire Dossier

Lomustine (Gleostine)

lomustine · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lomustine (Gleostine), covering 2025-10-09 to 2026-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma [Phase 3]

See pricing